1. In this randomized controlled trial, there was no significant difference in mortality between participants who received fever prevention for 36 versus 72 hours after cardiac arrest. 2. There was no significant difference in cognitive assessment or disability between participants who received fever prevention for 36 versus 72 hours at three months. Evidence Rating Level: